[1]
2020. Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone. SKIN The Journal of Cutaneous Medicine. 4, 3 (May 2020), 288–291. DOI:https://doi.org/10.25251/skin.4.3.15.